AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript November 14, 2022

AcelRx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.2.

Operator: Welcome to the AcelRx Third Quarter 2022 Earnings Call. This call is being webcast live via the Events page of the Investors section of AcelRx’s website at www.acelrx.com. This call is the property of AcelRx and any recording, reproduction, or transmission of this call without the...